Ticker: XBIT

XBiotech Inc. (NASDAQ: XBIT) - Q2 2025 brief What's happening inside: management cut clinical activity and operating costs in H1 2025, repaid a $10.0 million related-party convertible loan, and recognized significant non‑cash share‑based compensation tied to executive awards. The company remains ...